AzTrials
AzTrials

Genital ProlapseNCT07306715

Laparoscopic Pectopexy With and Without Mesh Use for Pelvic Organ Prolapse.

A study testing Meshless Laparoscopic Pectopexy and Laparoscopic Pectopexy with mesh in people with Genital Prolapse, run by Kocaeli University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Genital apical prolapse refers to the descent of the vaginal apex, uterus, or cervix, and surgical treatment is required for adequate apical support. Laparoscopic pectopexy is a surgical method developed as an alternative to the gold standard, sacrocolpopexy, in the treatment of genital organ prolapse, especially for… Read more about this study

Who is it for?
Ages 40 to 80 years, women only
Conditions the study is for
Genital Prolapse
What is being tested?
Meshless Laparoscopic Pectopexy and Laparoscopic Pectopexy with mesh
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
29 Jan 2026to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female patients older than 40 years and younger than 80 years old with symptomatic uterine prolapse
  • Patients who provided written consent for the surgical procedure
  • Patients who do not wish to preserve their uterus

Who cannot join

  • Patients who cannot obtain anesthesia approval for laparoscopic surgery
  • Patients who have a confirmed or suspected pregnancy
  • Patients who have abnormal uterine/cervical/vaginal bleeding
  • Patients with biopsy-confirmed endometrial hyperplasia or cervical dysplasia
  • Patients with pathology-confirmed genital cancer
  • Patients undergone chemotherapy or radiotherapy for any type of cancer

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Şener Gezer, M.D. contact

+903723037575

dr.senergezer@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Kocaeli University, School of Medicine

    Köseköy, Kocaeli, 41380

    Şener Gezer, Asoc. Prof. Dr., +90 372 303 2525, dr.senergezer@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Pectopexy Operations With and Without Mesh Use After Laparoscopic Hysterectomy for Pelvic Organ Prolapse.

Genital apical prolapse refers to the descent of the vaginal apex, uterus, or cervix, and surgical treatment is required for adequate apical support. Laparoscopic pectopexy is a surgical method developed as an alternative to the gold standard, sacrocolpopexy, in the treatment of genital organ prolapse, especially for obese patients for whom dissection is difficult. The vaginal cuff is attached to the pectineal ligament with polypropylene mesh in the standard technique. The use of mesh is subject to serious restrictions due to complications such as mesh erosion. Surgical methods without using a mesh may be safer treatment options for patients with genital prolapse. This study aimed to compare the results of Laparoscopic Pectopexy surgery with and without the use of mesh material after hysterectomy.

Read the detailed description

After ethics committee approval, patients with stage 2 and above pelvic organ prolapse according to the POP-Q staging system, who have completed their fertile period and do not want uterus preservation, will be included in the study. The stage of prolapse according to POP-Q and other gynecological examination findings will be recorded at the initial examination. Prolapse and its impact on the quality of life will be recorded preoperatively and 12 months postoperatively with the Prolapse Quality of Life Questionnaire (P-QOL). Patients will be called for examination 12 months after the operation. The ratio of women with stage 2 or greater vaginal cuff prolapse according to the Pelvic Organ Prolapse Quantification (POP-Q) system is the main outcome of the study.

Being tested
Meshless Laparoscopic Pectopexy, Laparoscopic Pectopexy with mesh
Keywords
pectopexy, mesh

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meshless Laparoscopic PectopexyProcedure or surgery

    The vaginal cuff will be fixed to the pectineal ligament with No. 1, non-absorbable Prolene suture.

  • Laparoscopic Pectopexy with meshProcedure or surgery

    The vaginal cuff will be fixed to the pectineal ligament with polypropylene mesh.

Study groups in NCT07306715
Study groupRoleWhat they receive
Laparoscopic Pectopexy without meshExperimentalIn this group of patients, the Laparoscopic Pectopexy operation will be performed without the use of mesh material after hysterectomy. Not using mesh will be protective against possible erosion reactions that may develop in the postoperative period. Laparoscopic hysterectomy is performed using the standard procedure with a uterine manipulator; after sealing the uterine arteries, the vagina is cut at the level of the uterine manipulator cuff and sutured. The vaginal cuff will be fixed to the pectineal ligament with No. 1, non-absorbable Prolene suture.
Receives: Procedure: Meshless Laparoscopic Pectopexy
Laparoscopic Pectopexy with meshActive comparatorIn this group of patients, the Laparoscopic Pectopexy operation will be performed using mesh material after hysterectomy. Laparoscopic hysterectomy is performed using the standard procedure with a uterine manipulator; after sealing the uterine arteries, the vagina is cut at the level of the uterine manipulator cuff and sutured. The vaginal cuff will be fixed to the pectineal ligament with polypropylene mesh.
Receives: Procedure: Laparoscopic Pectopexy with mesh

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Apical descensus relapse rate

    The ratio of women with stage 2 or greater vaginal cuff prolapse according to the Pelvic Organ Prolapse Quantification (POP-Q) system.

    Measured: 12 months after surgery

Secondary outcomes (1)
  1. Prolapse Quality of Life (P-QOL)

    The questionnaire has nine items, each of which has a 4-point scoring system and a total score of 0-100. A high total score indicates worsening of the quality of life of women with pelvic organ prolapse.

    Measured: Preoperative day and 12 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2025
  2. Study start29 Jan 2026
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07306715
Sponsor's protocol ID
KAEK/18.bI.02
Status last verified
Jan 2026
First submitted
14 Dec 2025
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Erdem B, Salman S, Usta ZK, Bacak HB, Ozkan MD, Ceken AT, Isik EY, Kumbasar S, Gencer FK, Baghaki HS, Kacar T, Aslan GN, Bulut B. A Novel Approach for Apical Prolapse Surgery: Meshless Pectopexy (Salman's Modification). Int Urogynecol J. 2025 Aug;36(8):1701-1705. doi: 10.1007/s00192-025-06107-z. Epub 2025 Apr 1.

    PubMed 40167602
  • Aleksandrov A, Smith AV, Rabischong B, Botchorishvili R. Mesh-less laparoscopic treatment of apical prolapse. Facts Views Vis Obgyn. 2021 Jun;13(2):179-181. doi: 10.52054/FVVO.13.2.013.

    PubMed 34184848

Questions about this trial

What is this clinical trial studying?

A study testing Meshless Laparoscopic Pectopexy and Laparoscopic Pectopexy with mesh in people with Genital Prolapse, run by Kocaeli University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Şener Gezer, M.D. (+903723037575, dr.senergezer@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Apical descensus relapse rate (time frame: 12 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07306715, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in